How Wall Street Hides Data from Retail, Silicon Valley's Effective Altruism | Martin Shkreli Talks
YouTube31 min 32 sec
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights
Consider establishing a long position in Ultragenyx Pharmaceutical (RARE) on pullbacks near $13, targeting $30 to $40 over a one-year horizon on drug commercialization and potential acquisition interest from BioMarin (BMRN).
Allocate core tech capital toward liquid large-cap semiconductor leaders like Taiwan Semiconductor (TSM), ASML Holding (ASML), and Lam Research (LRCX) for consistent gains rather than chasing volatile small-cap stocks.
Track international trading data from foreign suppliers like SK Hynix to gain an early directional edge on correlated memory and storage assets.
Look for short-term trading opportunities to fade morning price surges in AI infrastructure and GPU cloud providers like Nebius Group (NBIS) when rallies are driven by already-known industry news.
To protect your capital, limit individual trade sizing to 1% to 2% of your total portfolio so positions can comfortably absorb normal market swings.
Detailed Analysis
Ultragenyx Pharmaceutical Inc. (RARE)
- The hosts discussed a breaking announcement during the episode where RARE received FDA approval for its Sanfilippo treatment, which had been anticipated.
- The stock saw rapid price action, surging to $14 before settling around $13.
- Biotech stocks often experience "sell the news" reactions following an FDA approval because the market priced in the event in advance.
- The speaker expressed a bullish long-term position, noting that the company has secured two drug approvals in three months.
- Mention of a potential acquisition thesis, speculating that BioMarin Pharmaceutical (BMRN) could eventually acquire the company at $30, or the stock could reach $40 within a year.
- Acknowledged mixed market sentiment regarding the CEO, Emil Kakkis, but the speaker maintains confidence in the management and business pipeline.
Takeaways
- Consider holding or establishing a long position in RARE on post-approval pullbacks, targeting potential upside from commercialization or an eventual buyout at $30 to $40.
- Be prepared for holding periods of up to a year for acquisition or valuation catalysts to materialize, while remaining mindful of short-term volatility post-FDA announcements.
Nebius Group (NBIS) / GPU Cloud Providers
- The stock jumped 10% in pre-market trading following reports of significant price hikes on GPU compute due to tight supply.
- The speaker took advantage of the pre-market spike, noting that hardware shortages and pricing pressures were already widely understood across the industry, making the initial surge an overreaction.
- Emphasized the importance of trading execution and liquidity when capitalizing on news spikes in medium-to-large market cap tech stocks.
Takeaways
- Monitor news-driven morning price surges on AI and GPU infrastructure stocks for potential short-term fading opportunities if the catalyst merely confirms information already known by the market.
Large-Cap Semiconductor Leaders (ASML, TSM, LRCX, SK Hynix)
- Discussed key semiconductor equipment and manufacturing leaders, including ASML Holding (ASML), Taiwan Semiconductor (TSM), Lam Research (LRCX), and SK Hynix.
- Highlighted that focusing on consistent, small daily gains in highly liquid, high-quality semiconductor names often outperforms chasing volatile small-cap stocks.
- Noted the importance of tracking international data (such as Korean market movements in SK Hynix) when assessing related trades in memory and storage (e.g., SanDisk).
Takeaways
- Focus trading activity on high-liquidity large-cap semiconductor stocks that offer deep order books, allowing clean entries and exits without moving the bid-ask spread.
- Incorporate foreign market data into your analysis when trading interconnected tech supply chains.
Risk Management & Position Sizing Strategy
- Shifted from placing large single bets (e.g., 20% portfolio allocation with a tight -5% stop loss) to smaller sizing (e.g., 1% to 2% portfolio size per trade).
- Smaller position sizes allow the trade greater price elasticity (e.g., enduring a -20% drawdown without causing catastrophic portfolio damage).
- Institutional liquidity constraints: Entering or exiting large positions can shift stock prices by 20 cents on both sides, requiring 40 cents just to break even.
- Institutional order flow data (such as prime broker market share and dealer volume) gives institutional funds an edge over retail brokerages like Robinhood.
Takeaways
- Limit individual trade allocations to 1%–2% of total capital to avoid forced stop-outs on normal market volatility.
- Set clear profit targets, capitulation levels, and time horizons before entering any trade to prevent holding losing positions longer than intended.
Ask about this postAnswers are grounded in this post's content.
Video Description
🔴 USE CODE: THESHKRELIPILL for 30% OFF! https://app.godelterminal.com/?via=theshkrelipill
► What Can Elon Musk Do to Open AI When He's in the Government? https://youtu.be/naNLRtHTj3A
► Bitcoin Didn't Taste the Real Recession, Low Board Trust in Saylor,Slowing GLP Market https://youtu.be/BEo4UNnVY30
► The Future Of Nvidia, Intel & Apple in the New Era of Quantum Computing https://youtu.be/91IvNXqlv34
✅ [𝗣𝗔𝗬𝗣𝗔𝗟 𝗗𝗢𝗡𝗔𝗧𝗜𝗢𝗡𝗦]
https://paypal.me/theshkrelipill
[𝗢𝗥𝗜𝗚𝗜𝗡𝗔𝗟 𝗩𝗜𝗗𝗘𝗢]
https://www.youtube.com/watch?v=2Pb2db7P3z8&pp=0gcJCSQMAYcqIYzv
📖 [𝗠𝗔𝗥𝗧𝗜𝗡'𝗦 𝗕𝗢𝗢𝗞 𝗥𝗘𝗖𝗢𝗠𝗠𝗘𝗡𝗗𝗔𝗧𝗜𝗢𝗡𝗦 𝗙𝗥𝗢𝗠 𝗛𝗜𝗦 𝗟𝗜𝗩𝗘𝗦𝗧𝗥𝗘𝗔𝗠𝗦]
𝗙𝗨𝗟𝗟 𝗟𝗜𝗦𝗧 👉 https://pastebin.com/XiG8KHd6
📖 𝐒𝐭𝐞𝐟 𝐌𝐚𝐫𝐮𝐜𝐡: 𝐏𝐲𝐭𝐡𝐨𝐧 𝐅𝐨𝐫 𝐃𝐮𝐦𝐦𝐢𝐞𝐬
[BOOK] https://amzn.to/4eZ5aGh
[KINDLE] https://amzn.to/3U7QXPt
📖 𝐂𝐡𝐚𝐫𝐥𝐞𝐬 𝐏𝐞𝐭𝐳𝐨𝐥𝐝: 𝐂𝐨𝐝𝐞
[BOOK] https://amzn.to/4eYNXgk
[KINDLE] https://amzn.to/3U6eTCI
📖 𝗕𝗿𝗮𝗱 𝗝𝗮𝗰𝗼𝗯𝘀: 𝗛𝗼𝘄 𝘁𝗼 𝗠𝗮𝗸𝗲 𝗮 𝗙𝗲𝘄 𝗕𝗶𝗹𝗹𝗶𝗼𝗻 𝗗𝗼𝗹𝗹𝗮𝗿𝘀
[BOOK] https://amzn.to/47ogPMw
[KINDLE] https://amzn.to/4dTEUNv
[FREE AUDIO W/ FREE TRIAL] https://amzn.to/3B2r4K2
📖 𝗗𝗮𝘃𝗶𝗱 𝗗𝗲𝘂𝘁𝘀𝗰𝗵: 𝗧𝗵𝗲 𝗙𝗮𝗯𝗿𝗶𝗰 𝗼𝗳 𝗥𝗲𝗮𝗹𝗶𝘁𝘆: 𝗧𝗵𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗼𝗳 𝗣𝗮𝗿𝗮𝗹𝗹𝗲𝗹 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗲𝘀
[BOOK] https://amzn.to/4grS5Hp
[KINDLE] https://amzn.to/4d06R50
[FREE AUDIO W/ FREE TRIAL] https://amzn.to/4ebC2v5
[𝗧𝗜𝗠𝗘𝗦𝗧𝗔𝗠𝗣𝗦] | [💎] = tips, advice, gems
00:00 Returning from Europe & Mozart chocolates
00:19 Travel chaos: 8 hours stuck on a Rome tarmac
00:48 All In conference: Meeting fans vs. hunting for billionaires
02:20 Memes, Marc Benioff, and Jensen Huang
02:51 Sam Altman banter: "He who has the gold makes the rules"
03:48 Silicon Valley culture: Effective Altruism vs. EA's business-first approach
04:08 How EA shut down Maxis Studio after a 5-day server failure
06:06 Music nostalgia, My Chemical Romance & making bad beats
08:08 Kids saying wild things & American vs. Austrian parenting
10:00 The unglamorous reality of rock bands & music culture
13:56 Product Roadmap: Building a "hot market" earnings calendar
14:30 Trading Psychology: Cutting losses early & managing trader ego
15:13 Position Sizing: Institutional entry strategies & drawdown limits
16:18 💎] Kelly Criterion: Risk elasticity and dynamic trade sizing
17:05 Market Microstructure: Fading GPU news & bid-ask friction on large orders
17:57 💎] Order Impact: How 100k share orders move markets $0.40 & cap fund size
18:27 💎] Scalability: Small-cap vs. large-cap liquidity dynamics (Oracle example)
19:34 Level 2 Games: Spotting institutional inventory vs. predatory algo runs
20:00 Retail vs. Wall Street: Order flow transparency & broker dynamics
23:38 AI & Market Agents: Auto-screening volume vs. float anomalies via MCP
24:51 International Data: Why Korean retail flow matters for shorting SanDisk
26:00 💎] Trader Performance: Analyzing a 19% YTD return & daily profit discipline
27:12 💎] Employee ROI: Net Present Value (NPV) & productivity curves
28:38 Gemini AI hack for finding air-conditioned spots in Rome
29:04 Live Market Breakdown: FDA approval news
[𝗠𝗔𝗥𝗧𝗜𝗡'𝗦 𝗢𝗙𝗙𝗜𝗖𝗜𝗔𝗟 𝗬𝗢𝗨𝗧𝗨𝗕𝗘 𝗖𝗛𝗔𝗡𝗡𝗘𝗟𝗦]
🔴 𝗙𝘂𝗹𝗹 𝗟𝗶𝘃𝗲𝘀𝘁𝗿𝗲𝗮𝗺𝘀 𝗛𝗲𝗿𝗲: @realmartinshkreli
https://www.youtube.com/@realmartinshkreli/streams
🔴 𝗠𝗮𝗿𝘁𝗶𝗻'𝘀 𝗙𝗶𝗻𝗮𝗻𝗰𝗲 & 𝗖𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆 𝗟𝗲𝘀𝘀𝗼𝗻𝘀 @mrmartinshkreli8223
https://www.youtube.com/@mrmartinshkreli8223/videos
[𝗦𝗢𝗖𝗜𝗔𝗟𝗦]
𝗦𝗵𝗸𝗿𝗲𝗹𝗶'𝘀 𝗦𝗼𝗰𝗶𝗮𝗹: https://linktr.ee/martinshkreli
𝗦𝘂𝗽𝗽𝗼𝗿𝘁 𝗛𝗶𝘀 𝗦𝘁𝗿𝗲𝗮𝗺: https://streamlabs.com/martinshkreli2
𝗪𝗲𝗯𝘀𝗶𝘁𝗲: http://www.martinshkreli.com/
𝗚𝗶𝘁𝗵𝘂𝗯: https://github.com/martinshkreli
[𝗣𝗟𝗔𝗬𝗟𝗜𝗦𝗧𝗦]
https://www.youtube.com/@TheShkreliPill/playlists
[𝗙𝗜𝗡𝗔𝗡𝗖𝗘 𝗔𝗡𝗗 𝗜𝗡𝗩𝗘𝗦𝗧𝗜𝗡𝗚 𝗖𝗟𝗔𝗦𝗦 [𝟮𝟬𝟭𝟲] 𝗧𝗜𝗠𝗘𝗦𝗧𝗔𝗠𝗣𝗦 𝗔𝗡𝗗 𝗘𝗗𝗜𝗧𝗘𝗗]
https://www.youtube.com/playlist?list=PLBfupwmfhBrWnPtx_5Nm4OvhqmRXdD9AF
[𝗕𝗘𝗦𝗧 𝗢𝗙 𝗠𝗔𝗥𝗧𝗜𝗡 𝗦𝗛𝗞𝗥𝗘𝗟𝗜: 𝗜𝗱𝗲𝗮𝘀 & 𝗜𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄𝘀]
https://www.youtube.com/watch?v=M2aRJ4ljm0o&list=PLBfupwmfhBrVjLr-lRNa_tDjVatMA9S9d&index=19
[𝗢𝗣𝗧𝗜𝗢𝗡𝗦 𝗔𝗡𝗗 𝗦𝗛𝗢𝗥𝗧𝗜𝗡𝗚 𝗦𝗧𝗥𝗔𝗧𝗘𝗚𝗜𝗘𝗦 | 𝗠𝗮𝗿𝘁𝗶𝗻 𝗦𝗵𝗸𝗿𝗲𝗹𝗶]
https://www.youtube.com/playlist?list=PLBfupwmfhBrUm2y3lLiKSN4FDmly5vipV
[𝗗𝗥𝗨𝗚 𝗗𝗜𝗦𝗖𝗢𝗩𝗘𝗥𝗬 𝗣𝗥𝗢𝗖𝗘𝗦𝗦 & 𝗣𝗔𝗧𝗘𝗡𝗧 𝗗𝗨𝗥𝗔𝗧𝗜𝗢𝗡𝗦]
https://www.youtube.com/playlist?list=PLBfupwmfhBrU5M3f2OZ2BhPnaQyGwnnYn
[𝗜𝗡𝗩𝗘𝗦𝗧𝗜𝗡𝗚 & 𝗙𝗜𝗡𝗔𝗡𝗖𝗜𝗔𝗟 𝗟𝗘𝗦𝗦𝗢𝗡𝗦]
https://www.youtube.com/watch?v=yZMHBcQncgk&list=PLBfupwmfhBrXbXbKHdmk9nzjnO77Ok5qn&index=9
[𝗧𝗵𝗲 𝗙𝗧𝗫 / 𝗖𝗿𝘆𝗽𝘁𝗼 𝗖𝗿𝗮𝘀𝗵 𝗘𝗿𝗮 [𝟮𝟬𝟮𝟮] | 𝗠𝗮𝗿𝘁𝗶𝗻 𝗦𝗵𝗸𝗿𝗲𝗹𝗶]
https://www.youtube.com/watch?v=jklylG7pBF0&list=PLBfupwmfhBrWq8DwWFcnzKPf42WJtJ3Kd&index=4
[ ! ] The videos on my YouTube channel include material from Martin Shkreli’s livestreams. The use of the video material is authorized by Martin Shkreli
Any video material that appears identically in uploads from other YouTube channels is purely coincidental. I have no control over or ownership of such reuploads and am not aware of their relationship with the original creator.
[𝗔𝗙𝗙𝗜𝗟𝗜𝗔𝗧𝗘 𝗟𝗜𝗡𝗞 𝗗𝗜𝗦𝗖𝗟𝗔𝗜𝗠𝗘𝗥]
Amazon links above include affiliate commission or referrals.
I'm part of an affiliate network and I receive compensation from partnering website.
By purchasing product through this link you help supporting this channel.
About The Shkreli Pill
The Shkreli Pill
By @theshkrelipill
Martin Shkreli Livestream Highlights [ ! ] The videos on my YouTube channel include material from Martin Shkreli's livestreams.